JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1988) 118, 349-351       DOI: 10.1677/joe.0.1180349
© 1988 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Reilly, D. S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Reilly, D. S. J.

Hypercholesterolaemia and thyroid hormone status

D. St J. O'Reilly

Hypercholesterolaemia, through its association with coronary heart disease, is currently a major health problem in Western Society. If the recommendations of the British Hyperlipidaemia Association and its American counterparts are to be followed, it has been estimated that 49% of males over 40 years of age in the U.K. should modify their diet in an attempt to reduce their hypercholesterolaemia (Shepherd, Betteridge, Durrington et al. 1987; Shaper & Pocock, 1985). Additionally, as many as 31% may also require drug therapy (Shaper & Pocock, 1985), although others would not support medication on such a large scale (Jones, Hughes, Cramb & Clapham, 1988).

For over 50 years, changes in the serum cholesterol concentration have been a well-recognized feature in disturbances of thyroid function (Mason, Hunt & Hurxthal, 1930). In hypothyroidism, hypercholesterolaemia results from increases in circulating amounts of cholesterol in very low density lipoprotein, low density lipoprotein (LDL) and high density lipoprotein







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the Society for Endocrinology.